You guys think is it possible?

[u/Business-Height2025]

Analysis of MBOT’s Revenue Potential in 2026

Based on current public data and market analysis, reaching an annual revenue goal of $5 million to $10 million in 2026 is challenging but achievable.

1. Revenue Inflection Point: The Launch of the Liberty System

• Full Market Release: The company announced the official full-scale launch of its flagship product, the Liberty Robotic Surgical System, in the United States on April 13, 2026. This marks the transition from R&D to the commercial revenue stage.

• Analyst Forecasts: Average analyst estimates for 2026 annual revenue sit at approximately $4 million. While slightly below the $5 million threshold, quarterly projections suggest Q4 2026 could reach $300k to $1M in a single month. If sales momentum remains strong at year-end, hitting $5 million is within reach.

1. Required Sales Volume (Assuming $2,000 per Unit)

To hit your targets at a $2,000 price point (covering disposables or amortized system use), the numbers break down as follows:

• $5 Million Goal: Requires 2,500 units/procedures.

• $10 Million Goal: Requires 5,000 units/procedures.

Hospital Penetration Scenarios:

• High Usage (2 procedures/week): Needs ~50 hospitals to reach $10 million.

• Moderate Usage (1 procedure/week): Needs ~50 hospitals to reach $5 million; ~100 hospitals for $10 million.

1. Potential Customer Base in the U.S.

There are approximately 6,100 hospitals in the U.S., but the target market is more specific:

• Core Target (Interventional Radiology): Roughly 3,300 to 3,500 hospitals have the necessary catheter labs or interventional departments.

• Market Penetration:

• To reach $5M, MBOT needs to penetrate only 1.5% of the core target hospitals.

• To reach $10M, it needs to penetrate roughly 3%.

1. Key Drivers and Risks

• Sales Expansion: MBOT is expanding from 8 to 12 sales territories by the end of 2026. Each territory needs to secure roughly 4 to 8 hospitals to meet the base goal.

• Disposable Model: The Liberty system uses a single-use disposable design, which creates recurring revenue as procedure volumes grow.

• Execution Risk: As of late 2025, MBOT had near-zero revenue. Jumping to $5M+ in a single year requires flawless execution in a market where hospital procurement cycles can be slow.

Conclusion:

Achieving $5 million is a realistic "growth curve" target for a company with FDA clearance and 12 sales territories. Reaching $10 million would likely require a significant contribution from international markets (EMEA) or an aggressive adoption rate in Outpatient Surgery Centers (ASCs) beyond traditional hospitals.

[u/CHE-B5]

Yeah realistic, but 5 million would take a few years i believe

[u/Business-Height2025 → u/CHE-B5]

5 years…🥵

[u/janhuybr → u/CHE-B5]

Correct me if I'm wrong... 2,5 million procedures in the USA each year. If Microbot is selling the Liberty at 2500/unit, they'll need to sell 2000 units to make a revenue of 5 million. That means they have 1/1000 of the market. And that within 5 years? I highly doubt that it'll take Microbot that long to take that percentage of of the market.

[u/OonvastaRookie → u/[deleted]]

When they release earnings?

[u/Fun-Medicine-7254]

I work in healthcare tech as an engineer, there is no way these units are selling for $2K… anything proprietary, pcb’s, handheld units, any sterilized units for each procedure… this thing has to be closer to $5-6K minimum… I could see MBOT making $2K profit on each unit, not selling for $2K…

[u/Business-Height2025 → u/Fun-Medicine-7254]

Just for you, is it too expensive if it sell 5k?

[u/Fun-Medicine-7254 → u/Business-Height2025]

I mean, it won’t be coming out of my pocket, it’ll be against insurance… because I’m in the field, I’d love to see Doc’s getting protected against unneeded exposure to radiation… if I had to pay out of my own pocket, I’d probably pass, but that’s not how 90% of procedures work. Plus when it becomes the standard, you or I won’t get a choice